Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704457 · ClinicalTrials.gov registry record
Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
A clinical trial, sponsored by Kenneth Peters, MD.
- Completed
- Registry status
- 11
- Enrollment target
NCT00704457: Completed study, sponsored by Kenneth Peters, MD.
NCT00704457 is a clinical trial that has completed, run by Kenneth Peters, MD. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00704457 has completed, sponsored by Kenneth Peters, MD.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2004-02 |
| Est. Completion | 2007-12 |
What the finished NCT00704457 record still lists
NCT00704457 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00704457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00704457 about?
NCT00704457 is a clinical study titled "Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)". Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.
What is the current status of trial NCT00704457?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2004-02. Estimated completion is 2007-12.
Who is sponsoring clinical trial NCT00704457?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia